Tech Company Financing Transactions

Restore Medical Funding Round

On 3/18/2004, Restore Medical raised $26.5 million in Series C financing from Bessemer Venture Partners, CLS and MPM Capital.

Transaction Overview

Company Name
Announced On
3/18/2004
Transaction Type
Venture Equity
Amount
$26,500,000
Round
Series C
Investors

Bessemer Venture Partners (Lead Investor) (Steven Kraus)

CLS

MPM Capital (Ashley Dombkowski)

Proceeds Purpose
The company plans to use the proceeds to continue commercialzation of the Pillar System.

Company Information

Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
2800 Patton Road
St. Paul, MN 55113
USA
Email Address
Not Recorded
Overview
Restore Medical, Inc. (Nasdaq: REST) develops, manufactures and markets our proprietary Pillar palatal implant system, or Pillar System, an innovative, minimally invasive, implantable medical device to treat sleep disordered breathing, which includes obstructive sleep apnea, or OSA, and snoring.
Profile
Restore Medical LinkedIn Company Profile
Social Media
Restore Medical Company Twitter Account
Company News
Restore Medical News
Facebook
Restore Medical on Facebook
YouTube
Restore Medical on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Robert Paulson
  Robert Paulson LinkedIn Profile  Robert Paulson Twitter Account  Robert Paulson News  Robert Paulson on Facebook
Chief Financial Officer
Christopher Geyen
  Christopher Geyen LinkedIn Profile  Christopher Geyen Twitter Account  Christopher Geyen News  Christopher Geyen on Facebook
Vice President
Philip Radichel
  Philip Radichel LinkedIn Profile  Philip Radichel Twitter Account  Philip Radichel News  Philip Radichel on Facebook
VP - Marketing
Michael Kujak
  Michael Kujak LinkedIn Profile  Michael Kujak Twitter Account  Michael Kujak News  Michael Kujak on Facebook
VP - Operations
John Sopp
  John Sopp LinkedIn Profile  John Sopp Twitter Account  John Sopp News  John Sopp on Facebook
VP - R & D
Paul Buscemi
  Paul Buscemi LinkedIn Profile  Paul Buscemi Twitter Account  Paul Buscemi News  Paul Buscemi on Facebook
VP - Regulatory Affairs
David Bremseth
  David Bremseth LinkedIn Profile  David Bremseth Twitter Account  David Bremseth News  David Bremseth on Facebook
VP - Sales
Craig Palmer
  Craig Palmer LinkedIn Profile  Craig Palmer Twitter Account  Craig Palmer News  Craig Palmer on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/17/2004: UPEK venture capital transaction
Next: 3/19/2004: Maven Networks venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary